Improvement of Treatment Resistant Depression in a Patient With Primary Hypothyroidism and Thr92Ala5’ Type 2 Deiodinase Gene Polymorphism With Multiple Daily Doses of Triiodothyronine

Introduction: The augmentation pharmacologic therapy used in patients with treatment-resistant depression (TRD) includes drugs such as lithium, buspirone, triiodothyronine (LT3) and other drugs. We report a patient with TRD and primary hypothyroidism who responded to a combination of LT3, given in d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Ziyan, Sherin, Rinsha P V, Fonseca, Tatiana De Lourdes, Hoang, Thanh Duc, Shakir, Mohamed K M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265896/
http://dx.doi.org/10.1210/jendso/bvab048.1915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265896/
http://dx.doi.org/10.1210/jendso/bvab048.1915

Ejemplares similares